Library

5-EAPB

Extremely limited human data; doses above 140 mg strongly discouraged. Fatal case reported at ~500 mg combined with MDAI (blood concentration 6.45 mg/L). Acts as monoamine releasing agent with 5-HT2A/5-HT2B agonist properties; chronic use may risk valvular heart disease via 5-HT2B activation. Described as less stimulating than MDMA with predominantly serotonergic effects. Always test substance purity; reagents produce MDMA-like reactions.

Classification

  • Chemical: Amphetamine
  • Chemical: Benzofuran
  • Chemical: Phenethylamine
  • Psychoactive: Entactogen
  • Psychoactive: Psychedelic
  • Psychoactive: Stimulant
  • Tag: Empathogen
  • Tag: Habit-Forming
  • Tag: Research-Chemical
  • Tag: Substituted amphetamine

Effects

  • Stimulation
  • Pupil Dilation
  • Teeth Grinding
  • Temperature Regulation Suppression
  • Increased Heart Rate
  • Difficulty Urinating
  • Cognitive Euphoria
  • Empathy Affection And Sociability Enhancement
  • Anxiety
  • Euphoria
  • Increased Sociability
  • Mood Lift
  • Increased Music Appreciation
  • Tactile Enhancement
  • Color Enhancement
  • Increased Sexuality
  • Visual And Audiotory Hallucinations Itchiness
  • Closed Eye Visuals

Routes of Administration

Oral

Dosage

  • Threshold: 20–35 mg
  • Light: 40-60 mg
  • Common: 60-100 mg
  • Strong: 100-150 mg
  • Heavy: 150+ mg

Duration

  • Onset: 0.5-1 h
  • Comeup: 0.5-1 h
  • Peak: 1.5-3 h
  • Offset: 1-2 h
  • After Effects: 6-12 h
  • Total Duration: 4-8 h

Insufflated

Dosage

  • Threshold: 10–20 mg
  • Light: 30-40 mg
  • Common: 40-60 mg
  • Strong: 60-100 mg
  • Heavy: 100 mg

Duration

  • Onset: 0.08-0.17 h
  • Comeup: 0.25-0.5 h
  • Peak: 0.75-2 h
  • Offset: 2-3.5 h
  • After Effects: 3.5-10 h
  • Total Duration: 3-6 h

Harm Reduction

Check interactions before mixing substances, pay attention to dose spacing and hydration, and treat all dosage guidance as approximate rather than guaranteed safe.

Sources

Substance data is aggregated from the following public harm-reduction and reference sources.

Links

This static page is intended as a readable non-JS and prerender-friendly library export.

Get the full DrugsPRO experience

Open the interactive DrugsPRO app for search, saved items, interactions, and deeper harm reduction tools.

Get the PRO test kit. The simple, quick and reliable drug checking test kit. Visit https://protestkit.eu

5-EAPB - Guia de substâncias DrugsPRO

5-EAPB: Extremely limited human data; doses above 140 mg strongly discouraged. Fatal case reported at ~500 mg combined with MDAI (blood concentration 6.45 mg/L). Acts as monoamine releasing agent with 5-HT2A/5-HT2B agonist properties; chronic use may risk valvular heart disease via 5-HT2B activation

Related pages